… of noncommunicable diseases. The aim of the present study is to conduct a dose–response
meta… of total, subclasses and individual flavonoids and risk of cardiovascular disease (CVD). …

… to ascertain whether cardiac radiation dose is a predictor of major adverse cardiac events (…
NSCLC patients, cardiac radiation dose exposure is a modifiable cardiac risk factor for MACE …

… a no effect dose threshold for cardiovascular disease mortality in … Principal findings Our
comprehensive meta-analysis, … per unit dose for most subtypes of cardiovascular disease. We …

Objective This study aims to assess whether a standard intervention package of cardiovascular
disease (CVD) care was being delivered effectively, and if it was associated with …

… therapies, particularly for at-risk and already established cardiovascular patients. Indeed,
comprehensive cardiac rehabilitation and exercise training programs inclusive of education, …

… To our knowledge, the present study represents the largest and most comprehensive
evaluation of the dose-response association between sedentary time and CVD risk in the general …

… trials on colchicine for the treatment of cardiovascular diseases. Random-effects meta-…
received a fixed dose of 0.5 mg daily, whereas in the other 19 studies the dose ranged from …

OBJECTIVE: Many recommendations for aspirin in stable cardiovascular disease are based …
of low-dose aspirin (50-325 mg/d) in patients with stable cardiovascular disease. METHODS…

Purpose of Review The global prevalence of non-alcoholic fatty liver disease (NAFLD)
presents an unmet need in treating these, often asymptomatic, individuals. In this review, we …

… have not addressed whether lower doses of anthracyclines … doses of anthracycline-based
chemotherapy (Anth-bC) would be associated with the early onset of subclinical CV disease …